e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Risk factors, prevalence and consequences of COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Prevalence of undiagnosed COPD in patients with established cardiovascular diseases
L. C. Loh, N. Selvarajah, S. Mohan, W. S. Choo, I. Omar (Georgetown, Malaysia)
Source:
Annual Congress 2010 - Risk factors, prevalence and consequences of COPD
Session:
Risk factors, prevalence and consequences of COPD
Session type:
E-Communication Session
Number:
1742
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. C. Loh, N. Selvarajah, S. Mohan, W. S. Choo, I. Omar (Georgetown, Malaysia). Prevalence of undiagnosed COPD in patients with established cardiovascular diseases. Eur Respir J 2010; 36: Suppl. 54, 1742
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
High prevalence of undiagnosed COPD in patients with cardiovascular disease
Source: Annual Congress 2009 - Risk factors for COPD
Year: 2009
Coexistence of cardiovascular diseases in patients with COPD
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Prevalence of cardiovascular disease in COPD patients in the UK
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010
Coexisting cardiovascular diseases increase the risk of exacerbations in patients with COPD
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011
Prevalence of comorbidities in patients with COPD in south-Spain
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011
Frequency of occurrence of risk factors of cardiovascular diseases and assessment of the total cardiovascular risk in patients with chronic obstructive pulmonary disease (COPD).
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019
Prevalence of comorbid cardiovascular conditions in Russian patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 453s
Year: 2006
Prevalence and associated factors of osteoporosis among patients with chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010
The evaluation of systemic inflammation in COPD patients comorbided with cardiovascular diseases or diabetes mellitus
Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity
Year: 2011
Prevalence of COPD in vascular diseases
Source: International Congress 2015 – Prevalence of respiratory disease
Year: 2015
High prevalence and under-diagnosis of obstructive lung diseases in hospitalized patients in India
Source: Eur Respir J 2005; 26: Suppl. 49, 594s
Year: 2005
Prevalence of metabolic syndrome in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016
Prevalence and risk factors of depression in patients with COPD
Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care
Year: 2009
Screening for the risk of malnutrition in COPD patients
Source: Annual Congress 2008 - Impact of nursing interventions on the quality of care for COPD patients
Year: 2008
Exacerbations and mortality of COPD patients with cardiovascular disease in the UK
Source: Annual Congress 2010 - Comorbidity in obstructive airway disease
Year: 2010
Prevalence and underlying risk factors of clinically undiagnosed obstructive lung disease in internal medicine wards
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007
Metabolic syndrome in COPD patients without cardiovascular comorbidities: Co-existence or a different COPD phenotype?
Source: Annual Congress 2010 - COPD: phenotyping and monitoring
Year: 2010
Prevalence and underdiagnosis of COPD by disease severity in middle-aged and elderly
Source: Eur Respir J 2005; 26: Suppl. 49, 470s
Year: 2005
Prevalence of comorbidity in patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2001; 18: Suppl. 33, 209s
Year: 2001
The association between COPD and cardiovascular disorders
Source: International Congress 2017 – COPD and comorbid cardiovascular diseases
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept